Maxwell F, Maxwell I H, Glode L M
Mol Cell Biol. 1987 Apr;7(4):1576-9. doi: 10.1128/mcb.7.4.1576-1579.1987.
DNA including the coding sequence for the A chain of the mutant diphtheria toxin tox 176 was cloned. The cloned mature A-chain coding sequence showed a G-to-A transition at nucleotide 383 as the only difference from the wild-type sequence. This resulted in replacement of the glycine at position 128 by aspartic acid in the predicted amino acid sequence. A eucaryotic cell expression plasmid, pTH1-176, was constructed in which the tox 176 A-chain coding sequence was attached to a truncated metallothionein promoter. The toxicity of this construct, compared with that of the corresponding wild-type diphtheria toxin A-chain plasmid, pTH1, was assessed after transfection into the human 293 cell line by an indirect transient expression assay (I. H. Maxwell, F. Maxwell, and L. M. Glode, Cancer Res. 46:4660-4664, 1986). For the same effect, 15- to 30-fold more pTH1-176 than pTH1 was required, a result consistent with previous in vitro estimates of the diminished activity of the tox 176 A chain. Controlled expression of the cloned tox 176 A-chain coding sequence may provide a means of eliminating specific cell populations in an organism, for which purpose the wild-type diphtheria toxin A chain might prove too toxic.
克隆了包含突变型白喉毒素tox 176 A链编码序列的DNA。克隆的成熟A链编码序列在核苷酸383处出现了从G到A的转变,这是与野生型序列唯一的差异。这导致预测的氨基酸序列中第128位的甘氨酸被天冬氨酸取代。构建了一个真核细胞表达质粒pTH1 - 176,其中tox 176 A链编码序列连接到一个截短的金属硫蛋白启动子上。通过间接瞬时表达试验(I. H. 麦克斯韦、F. 麦克斯韦和L. M. 格洛德,《癌症研究》46:4660 - 4664, 1986)将该构建体转染到人293细胞系后,评估了其与相应野生型白喉毒素A链质粒pTH1相比的毒性。为达到相同效果,所需pTH1 - 176的量是pTH1的15至30倍,这一结果与之前对tox 176 A链活性降低所做的体外估计一致。克隆的tox 176 A链编码序列的可控表达可能提供一种消除生物体中特定细胞群体的方法,而野生型白喉毒素A链可能因毒性过大而无法用于此目的。